Integrating T cell signaling and metabolism to enhance T cell engager responses in solid tumors

Michael Scaglione1, Minal Engavale1, Matthew G Chun1

  • 1Amgen R&D Postdoctoral Fellows Program, South San Francisco, CA, United States.

Insights

Cellular metabolism significantly impacts T cell engager (TCE) therapy efficacy in solid tumors. Understanding metabolic rewiring is key to improving TCE design and patient outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Metabolism

Background:

  • T cell engagers (TCEs) show promise in hematologic malignancies and solid tumors.
  • Challenges remain in solid tumor TCE development, particularly maintaining T cell function in the tumor microenvironment (TME).
  • Cellular metabolism is increasingly recognized as a regulator of T cell function and a modulator of the TME.

Purpose of the Study:

  • To explore the role of cellular metabolism in regulating TCE responses within solid tumors.
  • To investigate how T cell signaling axes and TME metabolic cues influence TCE efficacy.
  • To propose metabolism as a critical factor for understanding and improving TCE therapy in solid tumors.

Main Methods:

  • Review of T cell signaling pathways (TCR, costimulatory, cytokine receptors) and their impact on metabolic rewiring.
  • Analysis of environmental factors within the TME, including nutrients and metabolic stressors.
  • Discussion of emerging methods for studying metabolic contributions to TCE responses.

Main Results:

  • Classical T cell signaling pathways induce metabolic changes essential for T cell function and fate.
  • TME metabolic perturbations, such as nutrient availability and stress, can negatively affect T cell responses and TCE efficacy.
  • Metabolism integrates signals from surface receptors and the TME to shape T cell function and therapeutic outcomes.

Conclusions:

  • Metabolism is a crucial, yet underexplored, factor in TCE efficacy and resistance in solid tumors.
  • Understanding the interplay between T cell signaling, metabolism, and immune programming is vital.
  • Targeting cellular metabolism offers a promising strategy for designing next-generation TCEs for solid tumors.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...